Literature DB >> 9258808

Pulmonary lymphangioleiomyoma in a patient with multiple endocrine neoplasia type I.

V Carnevale1, E Romagnoli, D Remotti, E D'Erasmo, G Spagna, D Pisani, R Rosso, S Minisola, G F Mazzuoli.   

Abstract

The multiple endocrine neoplasia (M.E.N.) syndromes consist of a group of proliferative disorders that selectively target specific sets of endocrine and soft tissue cells. Here we report a case of lymphangioleiomyoma of the lung in a patient with multiple endocrine neoplasia Type I (M.E.N. I). This is the first time such an association has been reported. In our opinion it could possibly be ascribed to the genetic predisposition to proliferative disorders of patients with M.E.N. syndromes.

Entities:  

Mesh：

Year:  1997        PMID： 9258808     DOI： 10.1007/BF03350301

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


  7 in total

1.  Multiple endocrine adenomatosis (Type 1) with cutaneous leiomyomata and cysts of Moll.

Authors:  J L Burton; M Hartog
Journal:  Br J Dermatol       Date:  1977-07       Impact factor: 9.302

2.  Efficacy of oophorectomy in lymphangioleiomyomatosis and benign metastasizing leiomyoma.

Authors:  A S Banner; C B Carrington; W B Emory; F Kittle; G Leonard; J Ringus; P Taylor; W W Addington
Journal:  N Engl J Med       Date:  1981-07-23       Impact factor: 91.245

3.  Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumor.

Authors:  M B Zimering; N Katsumata; Y Sato; M L Brandi; G D Aurbach; S J Marx; H G Friesen
Journal:  J Clin Endocrinol Metab       Date:  1993-05       Impact factor: 5.958

Review 4.  Leiomyoma of the lung. Literature review and case report.

Authors:  J M Vera-Román; R E Sobonya; J L Gomez-Garcia; J R Sanz-Bondia; F Paris-Romeu
Journal:  Cancer       Date:  1983-09-01       Impact factor: 6.860

Review 5.  Multiple endocrine neoplasia type 1. Clinical features and screening.

Authors:  B Skogseid; J Rastad; K Oberg
Journal:  Endocrinol Metab Clin North Am       Date:  1994-03       Impact factor: 4.741

Review 6.  Diagnosis of the multiglandular endocrine neoplasias.

Authors:  H G Bone
Journal:  Clin Chem       Date:  1990-05       Impact factor: 8.327

7.  Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1.

Authors:  M L Brandi; G D Aurbach; L A Fitzpatrick; R Quarto; A M Spiegel; M M Bliziotes; J A Norton; J L Doppman; S J Marx
Journal:  N Engl J Med       Date:  1986-05-15       Impact factor: 91.245
  7 in total
  2 in total

1.  Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1.

Authors:  J L McKeeby; X Li; Z Zhuang; A O Vortmeyer; S Huang; M Pirner; M C Skarulis; L James-Newton; S J Marx; I A Lubensky
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

2.  Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Marc J Berna; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2013-05       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.